Global Ophthalmic Viscoelastic Devices Market was valued at USD 2.40 billion in 2020, growing at a CAGR of 4.23% during the forecast period from 2021 to 2026, to reach USD 3.07 billion by 2026. The Ophthalmic Viscoelastic Devices market is expected to witness growth due to the rising prevalence of ophthalmic conditions like cataracts, glaucoma, and others, technological advancements, and the surge in the geriatric population.
Some of the Global Ophthalmic Viscoelastic Devices companies with their Ophthalmic Viscoelastic Devices in various stages of development include Bausch Health Companies Inc., Eyekon Medical Inc., Bohus BioTech AB, Carl Zeiss Meditec AG, CIMA Technology Inc., Johnson & Johnson Vision Care, Inc., Alcon Inc., Rumex International Corporation, Altacor, Ophtechnics Unlimited, Beaver Visitec Limited, PhysIOL, Neu Micromed International Pvt. Ltd., Rayner Intraocular Lenses Limited, Aurolab, Abbott Medical Optics, Maxigen Biotech Inc., Amring Pharmaceuticals Inc., Sight Sciences, Inc., Anika Therapeutics, Inc., and others are currently dominating the Ophthalmic Viscoelastic Devices Market.
DelveInsight’s “Ophthalmic Viscoelastic Devices Market Insights and Forecast” report provides the current and forecasted Ophthalmic Viscoelastic Devices Market trends for the next five years, upcoming innovations in the devices, individual Ophthalmic Viscoelastic Devices market share, challenges, drivers and barriers, and key competitors in the domain.
Ophthalmic Viscoelastic Devices: An Overview
Ophthalmologists use ophthalmic viscoelastic devices (OVDs) in multiple eye operations, such as cataract surgery, glaucoma surgery, among others. These devices help secure the fragile eye structures along with creating pressure in the anterior cavity, compartmentalizing the interior of the eye, and providing patients with faster healing for easier and safer surgery.
Are you interested to know how the Ophthalmic Viscoelastic Devices Market will be growing by 2026? If yes, click to get a snapshot of the Ophthalmic Viscoelastic Devices Porter’s Five Forces Analysis
Recent Breakthroughs in the Ophthalmic Viscoelastic Devices Market
In recent years, the Ophthalmic Viscoelastic Devices market observed expansions in terms of clinical, commercial, and clinical development.
- In June 2021, Rayner announced that it has acquired Surgicon Healthcare Pvt Limited in Mumbai, India. This acquisition helped Rayner to rapidly bring its strong pipeline of innovative intraocular lenses (IOLs), ophthalmic viscoelastic devices (OVDs), and dry eye drop solutions to surgeons and patients across India, and further develop its global presence.
- In April 2021, Bausch + Lomb announced that the FDA has approved its ClearVisc dispersive ophthalmic viscosurgical device (OVD) for use in ophthalmic surgery.
According to DelveInsight, the Ophthalmic Viscoelastic Devices Clinical Development market would rise rapidly throughout the forecast period due to continuous commercial and clinical development.
Key Players Proactively working in the Ophthalmic Viscoelastic Device Market Insights
In the global market for Ophthalmic Viscoelastic Device, key players contribute significantly to their development and are also active in mergers and acquisitions to strengthen their market position.
Some of the Ophthalmic Viscoelastic Device market companies operating actively in the Ophthalmic Viscoelastic Device included Bausch Health Companies Inc., Eyekon Medical Inc., Bohus BioTech AB, Carl Zeiss Meditec AG, CIMA Technology Inc., Johnson & Johnson Vision Care, Inc., Alcon Inc., Rumex International Corporation, Altacor, Ophtechnics Unlimited, Beaver Visitec Limited, Physiol, Neu Micromed International Pvt. Ltd., Rayner Intraocular Lenses Limited, Aurolab, Abbott Medical Optics, Maxigen Biotech Inc., Amring Pharmaceuticals Inc., Sight Sciences, Inc., Anika Therapeutics, Inc., and Others.
Learn more about the Ophthalmic Viscoelastic Device, get in-depth information @ Ophthalmic Viscoelastic Device Companies
COVID-19 Impact Analysis on Ophthalmic Viscoelastic Device Market
Along with the above-mentioned factors, the Ophthalmic Viscoelastic Devices market witnessed a period of temporary setback owing to the imposing of the lockdown restrictions as necessary measures to contain the COVID-19 spread. One of the major steps during this was the suspension of numerous elective procedures and outpatient visits which reduced the demand for Ophthalmic Viscoelastic Devices in the market as a large number of surgeries across different medical specialties were suspended during the initial lockdown period, thereby limiting the market growth for a short time.
Nevertheless, the market for Ophthalmic Viscoelastic Devices is in a period of recovery with the resumption of activities across various domains including healthcare services owing to the approval and administration of numerous COVID-19 vaccines across the globe, thereby presenting a positive future outlook for the Ophthalmic Viscoelastic Devices market during the forecast period from 2021-2026.
Request a snapshot of the report, just a click here to know @ Ophthalmic Viscoelastic Device Market Share
Scope of the Ophthalmic Viscoelastic Device Market
- Geography Covered- Global
- Study Period- 2021-2026
- Market Segmentation By Type- Cohesive Ophthalmic Viscoelastic, Dispersive Ophthalmic Viscoelastic, Combination Ophthalmic Viscoelastic, Visco-Adaptive Ophthalmic Viscoelastic
- Market Segmentation By Application- Cataract Surgery, Glaucoma Surgery, Corneal Transplantation, Vitreoretinal Surgery, Others
- Ophthalmic Viscoelastic Devices Market by End-User- Hospitals, Ophthalmology Clinics, Others.
- Ophthalmic Viscoelastic Devices Market by Geography- North America, Europe, Asia-Pacific, and Rest of the World.
- Key Global Ophthalmic Viscoelastic Devices Companies in the Market: Bausch Health Companies Inc. (NYSE: BHC), Eyekon Medical Inc., Bohus BioTech AB, Carl Zeiss Meditec AG, CIMA Technology Inc., Johnson & Johnson Vision Care, Inc., Alcon Inc. (NYSE: ALC), Rumex International Corporation, Altacor, Ophtechnics Unlimited, Beaver Visitec Limited, PhysIOL, Neu Micromed International Pvt. Ltd., Rayner Intraocular Lenses Limited, Aurolab, Abbott Medical Optics (NYSE: ABT), Maxigen Biotech Inc., Amring Pharmaceuticals Inc., Sight Sciences (NYSE: SGT), Anika Therapeutics Inc. (NYSE: ANIK), and others.
- Porter’s Five Forces Analysis, Product Profiles, Cases Studies, KOL’s Views, a0nd Analyst’s View
Table of content
1. Report Introduction
2. Executive summary
3. Regulatory and Patent Analysis
4. Key factors analysis
5. Porter’s Five Forces Analysis
6. COVID-19 Impact Analysis
7. Layout
8. Ophthalmic Viscoelastic Devices Global Company Share Analysis – Key 3-5 Companies
9. Company and Product Profiles
10. Project Approach
11. KOL Views
12. DelveInsight Capabilities
13. Disclaimer
14. About DelveInsight
For more details about the market size of Ophthalmic Viscoelastic Devices, just click here @ Ophthalmic Viscoelastic Device Market Size
Key Takeaways from the Ophthalmic Viscoelastic Devices Market Report Study
- Market size analysis for current Ophthalmic Viscoelastic Devices market size (2020), and market forecast for 5 years (2021-2026)
- The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Ophthalmic Viscoelastic Devices market.
- Top key product/services/technology developments, mergers, acquisitions, partnerships, joint ventures happened in the last 3 years
- Various opportunities are available for the other competitor in the Ophthalmic Viscoelastic Devices market space and dominating the global Ophthalmic Viscoelastic Devices market companies
- Which are the top-performing segments, regions, and countries in the current Ophthalmic Viscoelastic Devices market scenario in 2020?
- Which are the regions and countries where companies should have concentrated on opportunities for Ophthalmic Viscoelastic Devices market growth in the coming future?
Are you interested to get information about the Ophthalmic Viscoelastic Device Market? If yes, you are just one click away @ Ophthalmic Viscoelastic Device Regulatory and Patent Analysis
Related Reports
Ophthalmic Laser Devices Market
The Global Ophthalmic Laser Devices Market was valued at USD 1.25 billion in 2020, growing at a CAGR of 6.11% during the forecast period from 2021 to 2026, to reach USD 1.78 billion by 2026. Ophthalmic Laser Devices Companies include Alcon Laboratories, Inc., A.R.C. Laser GmbH, Johnson and Johnson Surgical Vision, Inc., Bausch & Lomb Incorporated, LENSAR Inc., Abbott Medical Optics, Inc., Ziemer Ophthalmic Systems, Carl Zeiss Meditec AG, INTERmedic Arfran, MEDA Co., Ltd., and Others.
The Global Ophthalmic Devices Market was valued at USD 53.72 billion in 2020, growing at a CAGR of 4.12% during the forecast period from 2021 to 2026 to reach USD 67.99 billion by 2026. Ophthalmic Devices Companies involved ZEISS Group, Leica Microsystems, CANON MEDICAL SYSTEMS EUROPE B.V., Optovue Incorporated, Heidelberg Engineering Inc, NIDEK CO., LTD, Luneau Technology Group, OPTOPOL Technology Sp. z o.o., Sonomed Escalon, Keeler, Konan Medical USA, Inc., TOMEY CORPORATION, Rexxam Co. Ltd., and Others.
Ophthalmic Ultrasound Systems Market
DelveInsight’s Ophthalmic Ultrasound Systems Market Insight, Competitive Landscape and Market Forecast, 2026’ report delivers an in-depth understanding of Ophthalmic Ultrasound Systems and the historical and forecasted Ophthalmic Ultrasound Systems market trends, globally, which comprises of North America, Europe, APAC, and RoW. Ophthalmic Ultrasound Systems Market Companies involved HAAG-Streit Holding AG, Johnson & Johnson, Nidek Co., Ltd., MicroMedical Devices, Inc., Sonomed Escalon, Quantel Medical, Keeler, DGH Technology, Inc., and Others.
Related Blogs by Delveinsight
- Development of Gene Therapies Dermatology
- How will Pharmacotherapies help the growing number of Presbyopes?
- Analyzing the Growth of the Biosimilar Market Through Years
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Get in touch with our team to get more detailed insights into how the MedTech Market is expected to evolve in the coming years and to formulate innovative business solutions, at MedTech Consulting Solutions
Contact Us
Yash Bhardwaj
info@delveinsight.com
+1(919)321-6187